Early Enhanced Expression of Interferon-Inducible Protein-10 (CXCL-10) and Other Chemokines Predicts Adverse Outcome in Severe Acute Respiratory Syndrome
- 1 December 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (12), 2333-2340
- https://doi.org/10.1373/clinchem.2005.054460
Abstract
Background: Exaggerated activation of cytokines/chemokines has been proposed as a factor in adverse outcome of severe acute respiratory syndrome (SARS). Previous studies on chemokines have included only small numbers of patients, and the utility of plasma chemokines as prognostic indicators is unclear. Methods: We studied 255 archival plasma samples collected during the first or second week after disease onset. The chemokines interferon-inducible protein-10 (IP-10), monokine induced by interferon-γ (MIG), interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), and regulated upon activation normal T cell expressed and secreted (RANTES) were measured by cytometric bead array with a 4-color FACSCalibur flow cytometer. Reverse transcription and real-time quantitative PCR and immunohistochemical staining were performed to analyze the production of IP-10 in lung tissue at autopsy. Conditional logistic regression was used to identify independent predictors for adverse disease outcome. Results: Increases in IP-10, MIG, and IL-8 during the first week after onset of fever were associated with adverse outcome (intensive care unit admission or death) in the univariate analysis. During the second week, only MIG concentration was associated with prognosis. After adjusting for other risk factors, plasma IP-10 concentration at the first week remained as an independent prognostic factor, with an odds ratio for adverse outcome of 1.52 (95% confidence interval, 1.05–2.55) per fold increase in plasma IP-10 concentration above the median. During the second week, chemokines provided little independent prognostic information. IP-10 was increased in lung tissue from patients who died of SARS. Conclusions: Increased plasma IP-10 during the first week of SARS symptoms is an independent predictor of outcome. Chemokine activation may be an early event in SARS, and an exaggerated host response may produce complications.Keywords
This publication has 33 references indexed in Scilit:
- Severe Acute Respiratory Syndrome, a Pathological Immune Response to the New Coronavirus—Implications for Understanding of Pathogenesis, Therapy, Design of Vaccines, and EpidemiologyViral Immunology, 2004
- Temporal Relationship of Viral Load, Ribavirin, Interleukin (IL)–6, IL‐8, and Clinical Progression in Patients with Severe Acute Respiratory SyndromeClinical Infectious Diseases, 2004
- The spectrum of pathological changes in severe acute respiratory syndrome (SARS)Histopathology, 2004
- Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS‐CoV) and its putative receptor, angiotensin‐converting enzyme 2 (ACE2)The Journal of Pathology, 2004
- Severe acute respiratory syndrome: report of treatment and outcome after a major outbreakThorax, 2004
- Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)Journal of Clinical Pathology, 2004
- Quantitative Analysis and Prognostic Implication of SARS Coronavirus RNA in the Plasma and Serum of Patients with Severe Acute Respiratory SyndromeClinical Chemistry, 2003
- SARS — beginning to understand a new virusNature Reviews Microbiology, 2003
- The clinical pathology of severe acute respiratory syndrome (SARS): a report from ChinaThe Journal of Pathology, 2003
- Host innate defenses in the lung: the role of cytokinesCurrent Opinion in Infectious Diseases, 2003